PSC
XENT

Piper Sandler & Co’s Intersect ENT, Inc XENT Stock Holding History

Piper Sandler & Co’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-3,645
Closed -$85K – 84
2015
Q3 		$85K Buy
+3,645
New +$101K 0.09% 91

Other funds holding XENT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KIA
Kopp Investment Advisors Bloomington, Minnesota $54.4M AUM 14.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Piper Sandler & Co's XENT Position: Q4 2015 in Review

Piper Sandler & Co sold out of Intersect ENT, Inc (XENT) in Q4 2015, closing a stake of 3,645 shares — an estimated $85K sold.

Piper Sandler & Co first reported a position in XENT in Q3 2015 and held it in 1 quarter. The position peaked at $85K in Q3 2015. 115 funds tracked by Wall St. Rank hold XENT as of Q4 2015.

  • Piper Sandler & Co reported no remaining Intersect ENT, Inc position as of Q4 2015 after selling out during the quarter.
  • Piper Sandler & Co sold 3,645 Intersect ENT, Inc shares in Q4 2015, an estimated $85K.
  • Piper Sandler & Co first reported a position in Intersect ENT, Inc in Q3 2015 and held it in 1 quarter.
  • Piper Sandler & Co's Intersect ENT, Inc position peaked at $85K in Q3 2015.
  • 115 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q4 2015.

Based on Piper Sandler & Co's 13F filing for Q4 2015, filed 16 Feb 2016.